Leveraging the public availability of RNA sequencing data, we performed analyses for MSI1 and MSI2 expression levels, finding that compared to benign lymphoid tissue MSI2 was upregulated in DLBCL tissues while MSI1 was not (Figure 2A, based on the GSE32018 dataset). This evidence concerns the gene MSI2 and diffuse large B-cell lymphoma.